The need for a concept-based medication vocabulary as an enabling infrastructure in health informatics

Users of drug information typically focus their attention at different levels of description in different situations, such as medication ordering or dispensing. Computer systems utilizing drug information to support such activities must accommodate these multiple perspectives. This paper presents an...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Proceedings. AMIA Symposium. - 1998. - (1998) vom: 13., Seite 865-9
1. Verfasser: Sperzel, W D (VerfasserIn)
Weitere Verfasser: Broverman, C A, Kapusnik-Uner, J E, Schlesinger, J M
Format: Aufsatz
Sprache:English
Veröffentlicht: 1998
Zugriff auf das übergeordnete Werk:Proceedings. AMIA Symposium
Schlagworte:Journal Article Pharmaceutical Preparations
LEADER 01000naa a22002652 4500
001 NLM098644599
003 DE-627
005 20231222112458.0
007 tu
008 231222s1998 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0329.xml 
035 |a (DE-627)NLM098644599 
035 |a (NLM)9929342 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sperzel, W D  |e verfasserin  |4 aut 
245 1 4 |a The need for a concept-based medication vocabulary as an enabling infrastructure in health informatics 
264 1 |c 1998 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 16.03.1999 
500 |a Date Revised 13.11.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Users of drug information typically focus their attention at different levels of description in different situations, such as medication ordering or dispensing. Computer systems utilizing drug information to support such activities must accommodate these multiple perspectives. This paper presents an approach to conceptualizing drug descriptions at multiple levels and outlines key features of an underlying information model that can serve as the basis for a concept-oriented medication vocabulary. These features include dose forms, routes of administration, as well as links to multiple drug classification schemes and medical problems. Implementation, standards, and maintenance issues related to the model are also discussed 
650 4 |a Journal Article 
650 7 |a Pharmaceutical Preparations  |2 NLM 
700 1 |a Broverman, C A  |e verfasserin  |4 aut 
700 1 |a Kapusnik-Uner, J E  |e verfasserin  |4 aut 
700 1 |a Schlesinger, J M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Proceedings. AMIA Symposium  |d 1998  |g (1998) vom: 13., Seite 865-9  |w (DE-627)NLM098642928  |x 1531-605X  |7 nnns 
773 1 8 |g year:1998  |g day:13  |g pages:865-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |j 1998  |b 13  |h 865-9